Eileen M. O'Reilly, MD

Medical Oncologist

Associate Director for Clinical Research, David M. Rubenstein Center for Pancreatic Cancer Research

Pictured: Eileen O'Reilly

About Me

I am a gastrointestinal medical oncologist with a major focus on treating pancreatic, biliary, primary liver cancers and other gastrointestinal malignancies. I work very closely with a team of surgeons, oncologists, and radiation therapists to determine and provide the best treatment for each patient with these diseases.

Read more

My research initiatives include developing methods to integrate molecular-based therapies into the treatment of pancreas cancer, and developing adjvuant and neoadjuvant therapy and new treatments for advanced disease.

At a national level, I am a member of CALGB’s gastrointestinal cancer committee and I also participate in other major co-operative oncology groups. At Memorial Sloan Kettering I am a member of the Institutional Review Board (IRB), Research Council, Clinical Council, and Electronic Chemotherapy Order Entry committees. My main educational focus is teaching and training oncology graduates nationally and internationally.

  • Clinical Expertise: Esophageal Cancer; Gastric Cancer; Pancreatic, Hepatobiliary, and Colorectal Cancers; Unknown Primary Tumors
  • Languages Spoken: English
  • Education: MD, Trinity College Dublin (Ireland)
  • Residencies: St. Vincent's Hospital (Dublin)
  • Fellowships: Memorial Sloan Kettering Cancer Center
  • Board Certifications: Internal Medicine (Ireland)

Appointments Available

Making an appointment

Call 646-497-9053
Mon–Fri, 8:30 AM–5:30 PM, ET

Publications

Visit PubMed for a full listing of Eileen M. O'Reilly’s journal articles

Pubmed is an online index of biomedical articles maintained by the U.S. National Library of Medicine and the National Institutes of Health.

Clinical Trials

Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.